Literature DB >> 11278578

A naturally processed rat major histocompatibility complex class I-associated viral peptide as target structure of borna disease virus-specific CD8+ T cells.

O Planz1, T Dumrese, S Hulpusch, M Schirle, S Stevanovic, L Stitz.   

Abstract

The first naturally processed peptide synthesized by a virus and recognized by classical CD8(+) T cells in association with the RT1.A(l) major histocompatibility complex class I molecule of the Lewis rat is reported. Borna disease virus-specific CD8(+) T cells recognize syngeneic target cells pulsed with peptides extracted from Borna disease virus-infected cells. The predicted peptide sequence ASYAQMTTY from the viral p40 protein coeluted with the cytotoxic T-lymphocyte-reactive fraction was identified among natural ligands by tandem mass spectrometry. Numerous naturally processed peptides derived from intracellular bacteria, viruses, or tumors and recognized by CD8(+) T cells of man and mice are known, leading to a better understanding of cellular immune mechanisms against pathogens in these two species. In contrast, for the rat little information exists with regard to the function and role of CD8(+) T cells as part of their cellular immune defense system. This first naturally processed viral epitope in the rat contributes to the understanding of the rat cellular immune response and might trigger the identification of more cytotoxic T-lymphocyte epitopes in this animal.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278578     DOI: 10.1074/jbc.M009889200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant.

Authors:  Marco Henkel; Oliver Planz; Timo Fischer; Lothar Stitz; Hanns-Joachim Rziha
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  High-dose Borna disease virus infection induces a nucleoprotein-specific cytotoxic T-lymphocyte response and prevention of immunopathology.

Authors:  E Furrer; T Bilzer; L Stitz; O Planz
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Constitutive activation of the transcription factor NF-kappaB results in impaired borna disease virus replication.

Authors:  Soizic Bourteele; Katja Oesterle; Stephan Pleschka; Gunhild Unterstab; Christina Ehrhardt; Thorsten Wolff; Stephan Ludwig; Oliver Planz
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Two major histocompatibility complex class I-restricted epitopes of the Borna disease virus p10 protein identified by cytotoxic T lymphocytes induced by DNA-based immunization.

Authors:  Yoshio Hashimoto; Horng-Shen Chen; Cynthia Cunningham; Tahir H Malik; Patrick K Lai
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Precursors of Borna disease virus-specific T cells in secondary lymphatic tissue of experimentally infected rats.

Authors:  Arvind Batra; Oliver Planz; Thomas Bilzer; Lothar Stitz
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

6.  Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor.

Authors:  Iwona Strug; J Mauricio Calvo-Calle; Karin M Green; John Cruz; Francis A Ennis; James E Evans; Lawrence J Stern
Journal:  J Proteome Res       Date:  2008-05-29       Impact factor: 4.466

7.  Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.

Authors:  Jan Wahlström; Jörn Dengjel; Bengt Persson; Hüseyin Duyar; Hans-Georg Rammensee; Stefan Stevanović; Anders Eklund; Robert Weissert; Johan Grunewald
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

8.  Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection.

Authors:  Alex S Hartlage; Satyapramod Murthy; Arvind Kumar; Sheetal Trivedi; Piyush Dravid; Himanshu Sharma; Christopher M Walker; Amit Kapoor
Journal:  Nat Commun       Date:  2019-03-07       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.